Just_Mom
Well-known member
By Rob Copeland and Rebecca Robbins
Rob Copeland covers Wall Street. Rebecca Robbins covers pharmaceuticals.
Sept. 10, 2025, 5:00 a.m. ET
The Trump administration has been mulling over some pretty strict limits on meds coming from China. If they actually happen, it could mess up the whole US drug industry, from generics to new treatments.
Basically, they're thinking about an executive order that would stop any new Chinese-made experimental drugs from getting in. Big pharma's been buying up rights to these drugs for stuff like cancer, obesity, heart issues, and Crohn's.
Word of this order (which the NYT got a hold of) has got investors and companies scrambling, 'cause there's billions on the line.
Big names like Peter Thiel, Sergey Brin, the Koch family, and even folks from Jared Kushner's investment firm are pushing for a serious crackdown, saying China's a major threat to US biotech. That's according to some insiders who wanted to stay anonymous.
Rob Copeland covers Wall Street. Rebecca Robbins covers pharmaceuticals.
Sept. 10, 2025, 5:00 a.m. ET
The Trump administration has been mulling over some pretty strict limits on meds coming from China. If they actually happen, it could mess up the whole US drug industry, from generics to new treatments.
Basically, they're thinking about an executive order that would stop any new Chinese-made experimental drugs from getting in. Big pharma's been buying up rights to these drugs for stuff like cancer, obesity, heart issues, and Crohn's.
Word of this order (which the NYT got a hold of) has got investors and companies scrambling, 'cause there's billions on the line.
Big names like Peter Thiel, Sergey Brin, the Koch family, and even folks from Jared Kushner's investment firm are pushing for a serious crackdown, saying China's a major threat to US biotech. That's according to some insiders who wanted to stay anonymous.